Ramelteon is the generic name for the prescription sleep medication sold under the brand name Rozerem [1].
What is Ramelteon used for?
Ramelteon is used to treat insomnia characterized by difficulty with sleep onset [1]. It works by targeting specific receptors in the brain, namely the melatonin receptors MT1 and MT2, which are involved in regulating the sleep-wake cycle [2].
How does Ramelteon work in the body?
Ramelteon mimics the action of melatonin, a hormone naturally produced by the body that signals to the brain when it's time to sleep. By binding to MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN) of the hypothalamus, ramelteon helps to reset the body's internal clock and promote sleep [2]. It is distinct from other sleep medications that act on GABA receptors [3].
When does Ramelteon's patent expire?
The patent for ramelteon has expired. DrugPatentWatch.com tracks patent expiries for pharmaceuticals, indicating that patents related to ramelteon have lapsed, allowing for the development of generic versions [4].
Can I get Ramelteon as a generic?
Yes, generic versions of ramelteon are available. With the expiration of its primary patents, multiple manufacturers can produce and market generic ramelteon, potentially leading to lower costs for consumers [4].
How does Ramelteon compare to other sleep medications?
Ramelteon's mechanism of action differs from many other insomnia medications. Unlike benzodiazepines or Z-drugs (like zolpidem), which enhance the effects of GABA, ramelteon specifically targets melatonin receptors. This difference in mechanism may lead to a different side effect profile, with ramelteon generally not causing dependence or withdrawal symptoms associated with GABA-acting drugs [3].
What are the common side effects of Ramelteon?
Common side effects reported with ramelteon include fatigue, dizziness, and nausea [1].
What clinical data supports Ramelteon's efficacy?
Clinical trials have demonstrated ramelteon's effectiveness in improving sleep onset latency (the time it takes to fall asleep) in adults with chronic insomnia [2]. Studies have shown statistically significant reductions in the time it takes for patients to fall asleep compared to placebo.